ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress

ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress

Yanting Lu, Shu Zhu, Xiaoyan Wang, Juhai Liu, Yingying Li, Wei Wang, Shijun Wang, Furong Wang College of TCM, Shandong University of Traditional Chinese Medicine, Jinan, 250355, People’s Republic of ChinaCorrespondence: Shijun Wang; Furong Wang Email wsj@sdutcm.edu.cn; 15168888786@163.comB...

Full description

Bibliographic Details
Main Authors:	Lu Y, Zhu S, Wang X, Liu J, Li Y, Wang W, Wang S, Wang F
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	Diabetes, Metabolic Syndrome and Obesity
Subjects:	diabetes myocardium shengmai-san oxidative stress ampk nox
Online Access:	https://www.dovepress.com/shengmai-san-attenuates-cardiac-remodeling-in-diabetic-rats-by-inhibit-peer-reviewed-article-DMSO

Similar Items

Combination of Shengmai San and Radix puerariae ameliorates depression‐like symptoms in diabetic rats at the nexus of PI3K/BDNF/SYN protein expression
by: Ayaz Ahmed, et al.
Published: (2023-06-01)

Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
by: Yiping Li, et al.
Published: (2019-09-01)

Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains
by: Shiya Liu, et al.
Published: (2021-12-01)

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
by: Zhenchao Niu, et al.
Published: (2022-04-01)

Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats
by: Yu You, et al.
Published: (2020-10-01)

Shengmai injection inhibits palmitic acid-induced myocardial cell inflammatory death via regulating NLRP3 inflammasome activation
by: Gang Yin, et al.
Published: (2023-11-01)

Altered synaptic currents, mitophagy, mitochondrial dynamics in Alzheimer's disease models and therapeutic potential of Dengzhan Shengmai capsules intervention
by: Binbin Zhao, et al.
Published: (2024-03-01)

The effect of Shengmai injection in patients with coronary heart disease in real world and its personalized medicine research using machine learning techniques
by: Jing Ma, et al.
Published: (2023-09-01)

Effect of optimized new Shengmai powder on exercise tolerance in rats with heart failure by regulating the ubiquitin-proteasome signaling pathway
by: Shuai Wang, et al.
Published: (2023-05-01)

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
by: Jianheng Pan, et al.
Published: (2021-08-01)

Shengmai Yin alleviated plaque vulnerability and ischemic myocardial damage in diesel exhaust particle-aggravated atherosclerosis with myocardial ischemia
by: Shuiqing Qu, et al.
Published: (2022-04-01)

Inhibition of NADPH Oxidase (NOX) 2 Mitigates Colitis in Mice with Impaired Macrophage AMPK Function
by: Suhrid Banskota, et al.
Published: (2023-05-01)

Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure
by: Zeyu Zhang, et al.
Published: (2024-02-01)

Efficacy and safety of Dengzhan Shengmai capsule in the treatment of chronic heart failure: a systematic review and meta-analysis
by: Shenghua Lu, et al.
Published: (2025-02-01)

Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
by: Jing-Yi Hou, et al.
Published: (2023-04-01)

Multiple ingredients of a Chinese medicine formula Sheng-Mai-San coordinately attenuate doxorubicin-induced cardiotoxicity
by: Meng Wang, et al.
Published: (2023-09-01)

Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway
by: Cunxiang Bo, et al.
Published: (2024-05-01)

A Strategy for Selecting “Q-Markers” of Chinese Medical Preparation via Components Transfer Process Analysis with Application to the Quality Control of Shengmai Injection
by: Chunxia Zhao, et al.
Published: (2019-05-01)

Clinical evidence-guided network pharmacology analysis reveals a critical contribution of β1-adrenoreceptor upregulation to bradycardia alleviation by Shenxian-Shengmai
by: Jiaming Gao, et al.
Published: (2019-12-01)

A Quantitative Serum Proteomic Analysis Helps to Explore the Comprehensive Mechanism and Identify Serum Biomarkers of Shengmai Injection’s Effect on Isoproterenol-Induced Myocardial Ischemia in Rats
by: Xiaoping Zhang, et al.
Published: (2021-04-01)

The cardioprotective effect of Shengmai Zhenwu decoction on patients with chronic heart failure based on the levels of soluble interleukin 1 receptor-like 1
by: Lei Zhang, et al.
Published: (2023-09-01)

HDAC inhibitor attenuates rat traumatic brain injury induced neurological impairments
by: Yiming Lu, et al.
Published: (2023-08-01)

Sheng-Mai San extracts attenuate heart injury in chronic intermittent hypoxia via suppressing oxidative damage and regulating glucose metabolism
by: Chunhua Liu, et al.
Published: (2022-12-01)

NoxO1 Determines the Level of ROS Formation by the Nox1-Centered NADPH Oxidase
by: Dana Maureen Hebchen, et al.
Published: (2024-09-01)

The Protective Effects of Shengmai Formula Against Myocardial Injury Induced by Ultrafine Particulate Matter Exposure and Myocardial Ischemia are Mediated by the PI3K/AKT/p38 MAPK/Nrf2 Pathway
by: Lina Chen, et al.
Published: (2021-03-01)

DOPAMINE EFFECT ON CARDIAC REMODELING IN EXPERIMENT
by: V. R. Veber, et al.
Published: (2016-01-01)

Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII/ERK1/2/MLCK and endothelial cell barrier dysfunction
by: Jinyao Jiang, et al.
Published: (2020-09-01)

Overexpression of NOX2 Exacerbates AngII-Mediated Cardiac Dysfunction and Metabolic Remodelling
by: Synne S. Hansen, et al.
Published: (2022-01-01)

Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
by: Bing Pang, et al.
Published: (2019-11-01)

DeNOxing the air in urban spaces by building and construction photocatalytic coverings
by: J. Fernández-Pampillón, et al.
Published: (2024-12-01)

NOX2 and NOX4 expression in monocytes and macrophages-extracellular vesicles in signalling and therapeutics
by: Deepak Rathi, et al.
Published: (2024-04-01)

Development of Ammonia Combustion Technology for NOx Reduction
by: Hossein Ali Yousefi Rizi, et al.
Published: (2025-03-01)

Effects of hydrogen addition on NOx formation in a non-premixed methane low-NOx combustor
by: Jiaying CHENG, et al.
Published: (2023-12-01)

The NADPH Oxidases Nox1 and Nox2 Differentially Regulate Volatile Organic Compounds, Fungistatic Activity, Plant Growth Promotion and Nutrient Assimilation in Trichoderma atroviride
by: Valter Cruz-Magalhães, et al.
Published: (2019-01-01)

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
by: Astrid Vandierendonck, et al.
Published: (2021-01-01)

Cobalt oxide with flake-like morphology as efficient passive NOx adsorber
by: Guohao Wu, et al.
Published: (2021-01-01)

Research on Application Characteristics of Zirconia-Based High-Temperature NOx Sensors
by: Jie Wang, et al.
Published: (2022-04-01)

Nox4 as a novel therapeutic target for diabetic vascular complications
by: Dongxia Wang, et al.
Published: (2023-08-01)

Reactive oxygen species derived from NOX3 and NOX5 drive differentiation of human oligodendrocytes
by: Roberta eAccetta, et al.
Published: (2016-06-01)

Modelling the production of NOx in coal burning
by: Èarnogurská Mária
Published: (2000-06-01)